Publicação

Patterns of outpatient proton‒pump inhibitors use among older adults in a duplicative health system

Ver documento

Detalhes bibliográficos
Resumo:Background: Proton-pump-inhibitors (PPIs) are overprescribed, posing challenges to patients and healthcare systems. In Portugal, the public National Health Service (NHS) provides universal coverage and reimburses medication regardless of prescription origin, i.e., public or private. This study aimed to compare PPIs outpatient prescription patterns and costs among older adults in the private and public sectors. Methods: A nationwide retrospective ecological study was conducted on PPIs prescribed for older adults in Portugal from 2020–2022. Data on defined daily doses (DDDs) and prices were obtained from a national public database by healthcare sector, sex, and age group (65–74, ≥ 75 years). The market share of DDD per 1000 older adults per day and the mean price per DDD (€/DDD) for all PPIs substances were compared between the public and private sectors. Results: PPIs-DDDs accounted for 5.3% of all outpatient DDDs prescribed in the private sector and 5.9% in the public sector. The private sector prescribed PPIs at a 20% higher price (0.126 €/DDD) than the public (0.106 €/DDD), with greater differences among the most expensive substances (rabeprazole, lansoprazole and esomeprazole). Omeprazole (cheapest) was mostly prescribed in the public sector. In the private sector, a similar pattern was observed among those aged ≥ 75 years, whereas esomeprazole was most prescribed for those aged 65–74 years. Conclusions: Given the widespread prescription of PPIs and the associated cost, it is crucial to reinforce incentives to promote rational PPIs prescription and encourage deprescription when necessary, in both sectors. Since the NHS also reimburses medications prescribed in private units, implementing monitoring measures and financial incentives to promote responsible prescribing in this sector should also be considered.
Autores principais:Romano, Sónia
Outros Autores:Rodrigues, António Teixeira; Torre, Carla; Perelman, Julian
Assunto:Overprescribing Patterns Private Proton-pump inhibitors Public Rational prescribing Health Policy SDG 3 - Good Health and Well-being
Ano:2025
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso aberto
Instituição associada:Universidade Nova de Lisboa
Idioma:inglês
Origem:Repositório Institucional da UNL
_version_ 1868982810190020608
author Romano, Sónia
author2 Rodrigues, António Teixeira
Torre, Carla
Perelman, Julian
author2_role author
author
author
author_facet Romano, Sónia
Rodrigues, António Teixeira
Torre, Carla
Perelman, Julian
author_role author
contributor_name_str_mv Centro de Investigação em Saúde Pública (CISP/PHRC)
Comprehensive Health Research Centre (CHRC) - Pólo ENSP
Escola Nacional de Saúde Pública (ENSP)
BioMed Central (BMC)
RUN
country_str PT
creators_json_txt [{\"Person.name\":\"Romano, Sónia\"},{\"Person.name\":\"Rodrigues, António Teixeira\"},{\"Person.name\":\"Torre, Carla\"},{\"Person.name\":\"Perelman, Julian\"}]
datacite.contributors.contributor.contributorName.fl_str_mv Centro de Investigação em Saúde Pública (CISP/PHRC)
Comprehensive Health Research Centre (CHRC) - Pólo ENSP
Escola Nacional de Saúde Pública (ENSP)
BioMed Central (BMC)
RUN
datacite.creators.creator.creatorName.fl_str_mv Romano, Sónia
Rodrigues, António Teixeira
Torre, Carla
Perelman, Julian
datacite.date.Accepted.fl_str_mv 2025-12-01T00:00:00Z
datacite.date.available.fl_str_mv 2025-05-20T21:21:34Z
datacite.date.embargoed.fl_str_mv 2025-05-20T21:21:34Z
datacite.rights.fl_str_mv http://purl.org/coar/access_right/c_abf2
datacite.subjects.subject.fl_str_mv Overprescribing
Patterns
Private
Proton-pump inhibitors
Public
Rational prescribing
Health Policy
SDG 3 - Good Health and Well-being
datacite.titles.title.fl_str_mv Patterns of outpatient proton‒pump inhibitors use among older adults in a duplicative health system
comparing public and private prescribing
dc.contributor.none.fl_str_mv Centro de Investigação em Saúde Pública (CISP/PHRC)
Comprehensive Health Research Centre (CHRC) - Pólo ENSP
Escola Nacional de Saúde Pública (ENSP)
BioMed Central (BMC)
RUN
dc.creator.none.fl_str_mv Romano, Sónia
Rodrigues, António Teixeira
Torre, Carla
Perelman, Julian
dc.date.Accepted.fl_str_mv 2025-12-01T00:00:00Z
dc.date.available.fl_str_mv 2025-05-20T21:21:34Z
dc.date.embargoed.fl_str_mv 2025-05-20T21:21:34Z
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv http://hdl.handle.net/10362/183246
dc.language.none.fl_str_mv eng
dc.rights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.subject.none.fl_str_mv Overprescribing
Patterns
Private
Proton-pump inhibitors
Public
Rational prescribing
Health Policy
SDG 3 - Good Health and Well-being
dc.title.fl_str_mv Patterns of outpatient proton‒pump inhibitors use among older adults in a duplicative health system
comparing public and private prescribing
dc.type.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
description Background: Proton-pump-inhibitors (PPIs) are overprescribed, posing challenges to patients and healthcare systems. In Portugal, the public National Health Service (NHS) provides universal coverage and reimburses medication regardless of prescription origin, i.e., public or private. This study aimed to compare PPIs outpatient prescription patterns and costs among older adults in the private and public sectors. Methods: A nationwide retrospective ecological study was conducted on PPIs prescribed for older adults in Portugal from 2020–2022. Data on defined daily doses (DDDs) and prices were obtained from a national public database by healthcare sector, sex, and age group (65–74, ≥ 75 years). The market share of DDD per 1000 older adults per day and the mean price per DDD (€/DDD) for all PPIs substances were compared between the public and private sectors. Results: PPIs-DDDs accounted for 5.3% of all outpatient DDDs prescribed in the private sector and 5.9% in the public sector. The private sector prescribed PPIs at a 20% higher price (0.126 €/DDD) than the public (0.106 €/DDD), with greater differences among the most expensive substances (rabeprazole, lansoprazole and esomeprazole). Omeprazole (cheapest) was mostly prescribed in the public sector. In the private sector, a similar pattern was observed among those aged ≥ 75 years, whereas esomeprazole was most prescribed for those aged 65–74 years. Conclusions: Given the widespread prescription of PPIs and the associated cost, it is crucial to reinforce incentives to promote rational PPIs prescription and encourage deprescription when necessary, in both sectors. Since the NHS also reimburses medications prescribed in private units, implementing monitoring measures and financial incentives to promote responsible prescribing in this sector should also be considered.
dirty 0
eu_rights_str_mv openAccess
format article
fulltext.url.fl_str_mv https://run.unl.pt/bitstreams/390bd578-88df-4d44-bdad-12875409fc94/download
id run_fb17cc2da9397f04733db94b340c8f25
identifier.url.fl_str_mv http://hdl.handle.net/10362/183246
inst_facet_str urn:organizationAcronym:unl{{{_:::_}}}Universidade Nova de Lisboa
instacron_str unl
institution Universidade Nova de Lisboa
instname_str Universidade Nova de Lisboa
language eng
network_acronym_str run
network_name_str Repositório Institucional da UNL
oai_identifier_str oai:run.unl.pt:10362/183246
organization_str_mv urn:organizationAcronym:unl
person_str_mv Romano, Sónia
Rodrigues, António Teixeira
Torre, Carla
Perelman, Julian
publishDate 2025
repo_facet_str urn:repositoryAcronym:run{{{_:::_}}}Repositório Institucional da UNL
reponame_str Repositório Institucional da UNL
repository_id_str urn:repositoryAcronym:run
service_str_mv urn:repositoryAcronym:run
spelling engenBackground: Proton-pump-inhibitors (PPIs) are overprescribed, posing challenges to patients and healthcare systems. In Portugal, the public National Health Service (NHS) provides universal coverage and reimburses medication regardless of prescription origin, i.e., public or private. This study aimed to compare PPIs outpatient prescription patterns and costs among older adults in the private and public sectors. Methods: A nationwide retrospective ecological study was conducted on PPIs prescribed for older adults in Portugal from 2020–2022. Data on defined daily doses (DDDs) and prices were obtained from a national public database by healthcare sector, sex, and age group (65–74, ≥ 75 years). The market share of DDD per 1000 older adults per day and the mean price per DDD (€/DDD) for all PPIs substances were compared between the public and private sectors. Results: PPIs-DDDs accounted for 5.3% of all outpatient DDDs prescribed in the private sector and 5.9% in the public sector. The private sector prescribed PPIs at a 20% higher price (0.126 €/DDD) than the public (0.106 €/DDD), with greater differences among the most expensive substances (rabeprazole, lansoprazole and esomeprazole). Omeprazole (cheapest) was mostly prescribed in the public sector. In the private sector, a similar pattern was observed among those aged ≥ 75 years, whereas esomeprazole was most prescribed for those aged 65–74 years. Conclusions: Given the widespread prescription of PPIs and the associated cost, it is crucial to reinforce incentives to promote rational PPIs prescription and encourage deprescription when necessary, in both sectors. Since the NHS also reimburses medications prescribed in private units, implementing monitoring measures and financial incentives to promote responsible prescribing in this sector should also be considered.application/pdfenPatterns of outpatient proton‒pump inhibitors use among older adults in a duplicative health systemSubtitleencomparing public and private prescribingRomano, SóniaRodrigues, António TeixeiraTorre, CarlaPerelman, JulianCentro de Investigação em Saúde Pública (CISP/PHRC)Comprehensive Health Research Centre (CHRC) - Pólo ENSPEscola Nacional de Saúde Pública (ENSP)BioMed Central (BMC)HostingInstitutionOrganizationalRUNe-mailmailto:run@unl.ptrun@unl.ptISSNIsPartOf1472-6963URNIsPartOfPURE: 116481395URNIsPartOfPURE UUID: 6881a7f0-b7e3-4d89-8445-c1b3d5f61d37URNIsPartOfScopus: 85214237176URNIsPartOfPubMed: 39762802URNIsPartOfPubMedCentral: PMC11706009URNIsPartOfWOS: 001391565500001DOIIsPartOf10.1186/s12913-024-12033-52025-05-20T21:21:34Z2025-122025-12-01T00:00:00ZHandlehttp://hdl.handle.net/10362/183246http://purl.org/coar/access_right/c_abf2open accessOverprescribingPatternsPrivateProton-pump inhibitorsPublicRational prescribingHealth PolicySDG 3 - Good Health and Well-being1262767 bytesliteraturehttp://purl.org/coar/resource_type/c_6501journal articlehttp://purl.org/coar/access_right/c_abf2application/pdffulltexthttps://run.unl.pt/bitstreams/390bd578-88df-4d44-bdad-12875409fc94/download
spellingShingle Patterns of outpatient proton‒pump inhibitors use among older adults in a duplicative health system
Romano, Sónia
Overprescribing
Patterns
Private
Proton-pump inhibitors
Public
Rational prescribing
Health Policy
SDG 3 - Good Health and Well-being
status SINGLETON
subject.fl_str_mv Overprescribing
Patterns
Private
Proton-pump inhibitors
Public
Rational prescribing
Health Policy
SDG 3 - Good Health and Well-being
title Patterns of outpatient proton‒pump inhibitors use among older adults in a duplicative health system
title_full Patterns of outpatient proton‒pump inhibitors use among older adults in a duplicative health system
title_fullStr Patterns of outpatient proton‒pump inhibitors use among older adults in a duplicative health system
title_full_unstemmed Patterns of outpatient proton‒pump inhibitors use among older adults in a duplicative health system
title_short Patterns of outpatient proton‒pump inhibitors use among older adults in a duplicative health system
title_sort Patterns of outpatient proton‒pump inhibitors use among older adults in a duplicative health system
topic Overprescribing
Patterns
Private
Proton-pump inhibitors
Public
Rational prescribing
Health Policy
SDG 3 - Good Health and Well-being
topic_facet Overprescribing
Patterns
Private
Proton-pump inhibitors
Public
Rational prescribing
Health Policy
SDG 3 - Good Health and Well-being
url http://hdl.handle.net/10362/183246
visible 1